Download Data
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells 11.2
iPSC v11.2 is available with new cell lines added for subjects from study 115 (PI: Hallmayer; R33MH087898). This update adds new iPSCs generated by a secondary investigator (Ilyas Singec), from 34 subjects already present in the Phelan McDermid Syndrome (PMS) collection. Those subjects are now cross-listed in the iPSC distribution and supplemental files. In addition to the lines generated by Ilyas Singec, 2 more iPSC samples generated by the original PI for a previously released subject have also been added. The distribution total is 802 individuals. There are 572 FCLs, 433 iPSCs, and 8 OEs.
Standard Data & Documentation
Download All- Distribution Bundle [text or excel]: Standard files across disorders, containing demographic, diagnostic, and pedigree information. Sampled (formerly IBX) sample IDs (nrgr_bio_id) and consent level are also provided. Bundle includes data dictionaries.
- Study Descriptions.
- Pedigree Drawings.
Additional Data Files
This study does not have any additional genetic or clinical data. All study data is included in the standard distribution files above.
Clinical Instruments
iPSC Submitter Form
- Study 115 Singec iPSC Submitter Form [text or excel] The iPSC Submitter Form contains one row per iPSC line received, and records the provenance of the cell line (source/parental cell line IDs), genetic diagnosis and/or modifications, passage number, cell growth conditions and reprogramming conditions at the time of cell line submission. For final conditions after successful regrowth and banking at IBX, see the Certificate of Analysis.
Other
This study does not have any additional genetic or clinical data. All study data is included in the standard distribution files above.
Study 127
Target Identification and Validation for Negative Symptoms and Social Cognition in Schizophrenia: A Translational Study
8
This study does not have any additional genetic or clinical data. All study data is included in the standard distribution files above.
This study does not have any additional genetic or clinical data. All study data is included in the standard distribution files above.
This study does not have any additional genetic or clinical data. All study data is included in the standard distribution files above.
Study 132
NIMH DIRP Protocol 03-M-0035 Screening, Evaluation, Diagnosis, Treatment Optimization and Follow-Up for Childhood Onset Psychiatric Disorders
228
This study does not have any additional genetic or clinical data. All study data is included in the standard distribution files above.
This study does not have any additional genetic or clinical data. All study data is included in the standard distribution files above.
This study does not have any additional genetic or clinical data. All study data is included in the standard distribution files above.
This study does not have any additional genetic or clinical data. All study data is included in the standard distribution files above.
This study does not have any additional genetic or clinical data. All study data is included in the standard distribution files above.
This study does not have any additional genetic or clinical data. All study data is included in the standard distribution files above.
This study does not have any additional genetic or clinical data. All study data is included in the standard distribution files above.
This study does not have any additional genetic or clinical data. All study data is included in the standard distribution files above.
This study does not have any additional genetic or clinical data. All study data is included in the standard distribution files above.
Study 115 — Exploring the Neuronal Phenotype of Autism Spectrum Disorders Using iPSCs
- Study 115 Singec iPSC Submitter Form [text or excel] The iPSC Submitter Form contains one row per iPSC line received, and records the provenance of the cell line (source/parental cell line IDs), genetic diagnosis and/or modifications, passage number, cell growth conditions and reprogramming conditions at the time of cell line submission. For final conditions after successful regrowth and banking at IBX, see the Certificate of Analysis.
Study 115 — Exploring the Neuronal Phenotype of Autism Spectrum Disorders Using iPSCs
- Phenotypic Data [text or excel] Includes demographics, diagnoses, body measurements, brain scan data, and summary data from ADI-R, ADOS, Mullen, SRS instruments. Additional subjects for study 115 can be found in the Phelan-McDermid Syndrome (PMS) collection.
Study 116 — Cellular and genetic correlates of increased head size in autism spectrum disorder
- Phenotypic Data [text or excel] Includes item-level data for ADI, ADOS, DAS, Mullen, Vineland, and WISC instruments, along with NDA linking IDs.
Study 117 — Autism iPSCs for Studying Function and Dysfunction in Human Neural Development
- Phenotypic Data [text or excel] Includes demographics, diagnosis, and summary data from ADI, ADOS, and Stanford-Binet
Study 158 — Modeling schizophrenia using iPSC neurons
Study 166 — Juvenile Onset Schizophrenia iPSCs
- Study 166 Phenotypic Data [text or excel] s166-misc-phen (n=8) includes medications at time of biopsy and Children’s Global Assessment Score.
Study 200 — Mechanisms of Circuit Failure and Treatments in Patient-derived Neurons in Autism